Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries-Reference-Cited by-同舟云学术

Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries

Published:2015-10-07 Issue:1 Volume:34 Page:59-76
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Heintz Emelie, ,Gerber-Grote Andreas,Ghabri Salah,Hamers Francoise F.,Rupel Valentina Prevolnik,Slabe-Erker Renata,Davidson Thomas

Funder

Executive Agency for Health and Consumers (LU)

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-015-0328-1.pdf

Reference63 articles.

1. European Network for Health Technology Assessment [EUnetHTA] JA 2 WP 8. HTA Core Model® (version 2.0 PDF): EUnetHTA—European Network for Health Technology Assessment. 2013.

2. European Network for Health Technology Assessment [EUnetHTA]. EUnetHTA: about us. EUnetHTA. 2015. http://www.eunethta.eu/about-us . Accessed 4 Sept 2015.

3. Drummond MF. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.

4. Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.

5. Glick H, Doshi J, Sonnad S, Plsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2007.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the reliability of a novel cancer-specific multi-attribute utility instrument (FACT-8D) and comparing its validity to EQ-5D-5L in colorectal cancer patients;Quality of Life Research;2024-09-03

2. Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance;Journal of Market Access & Health Policy;2024-05-20

3. Digital Alcohol Interventions Could Be Part of the Societal Response to Harmful Consumption, but We Know Little About Their Long-Term Costs and Health Outcomes;Journal of Medical Internet Research;2024-03-27

4. Danish value sets for the EORTC QLU-C10D utility instrument;Quality of Life Research;2024-01-06

5. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective;Value in Health;2023-12